Terms: = Brain cancer AND CCDC6, D10S170, 8030, ENSG00000108091, Q16204, TPC, H4, TST1
127 results:
1. Tumor suppressor role of the complement inhibitor CSMD1 and its role in TNF-induced neuroinflammation in gliomas.
Tuysuz EC; Mourati E; Rosberg R; Moskal A; Gialeli C; Johansson E; Governa V; Belting M; Pietras A; Blom AM
J Exp Clin Cancer Res; 2024 Apr; 43(1):98. PubMed ID: 38561856
[TBL] [Abstract] [Full Text] [Related]
2. A subregion-based RadioFusionOmics model discriminates between grade 4 astrocytoma and glioblastoma on multisequence MRI.
Wei R; Lu S; Lai S; Liang F; Zhang W; Jiang X; Zhen X; Yang R
J Cancer Res Clin Oncol; 2024 Feb; 150(2):73. PubMed ID: 38305926
[TBL] [Abstract] [Full Text] [Related]
3. Spatial and temporal heterogeneity of tumor immune microenvironment between primary tumor and brain metastases in NSCLC.
Liu JS; Cai YX; He YZ; Xu J; Tian SF; Li ZQ
BMC Cancer; 2024 Jan; 24(1):123. PubMed ID: 38267913
[TBL] [Abstract] [Full Text] [Related]
4. Therapeutic strategy using novel RET/YES1 dual-target inhibitor in lung cancer.
Choi YJ; Choi M; Park J; Park M; Kim MJ; Lee JS; Oh SJ; Lee YJ; Shim WS; Kim JW; Kim MJ; Kim YC; Kang KW
Biomed Pharmacother; 2024 Feb; 171():116124. PubMed ID: 38198957
[TBL] [Abstract] [Full Text] [Related]
5. The iron chelator and OXPHOS inhibitor VLX600 induces mitophagy and an autophagy-dependent type of cell death in glioblastoma cells.
Reisbeck L; Linder B; Tascher G; Bozkurt S; Weber KJ; Herold-Mende C; van Wijk SJL; Marschalek R; Schaefer L; Münch C; Kögel D
Am J Physiol Cell Physiol; 2023 Dec; 325(6):C1451-C1469. PubMed ID: 37899749
[TBL] [Abstract] [Full Text] [Related]
6. SPI1-mediated MIR222HG transcription promotes proneural-to-mesenchymal transition of glioma stem cells and immunosuppressive polarization of macrophages.
Fan Y; Gao Z; Xu J; Wang H; Guo Q; Li B; Li M; Xu H; Qi Y; Zhao S; Qiu W; Pan Z; Wang Q; Xue H; Zhao R; Guo X; Li G
Theranostics; 2023; 13(10):3310-3329. PubMed ID: 37351164
[No Abstract] [Full Text] [Related]
7. Intracranial Activity of Selpercatinib in Chinese Patients With Advanced
Cheng Y; Huang D; Zhou J; Zhou C; Sun Y; Wu L; Guo Y; Jingxin S; Zhang W; Lu S
JCO Precis Oncol; 2023 Jun; 7():e2200708. PubMed ID: 37315261
[TBL] [Abstract] [Full Text] [Related]
8. The interaction between
Zhang Z; Liu S
Ann Med; 2023 Dec; 55(1):1111-1122. PubMed ID: 36947060
[TBL] [Abstract] [Full Text] [Related]
9. Central Nervous System Disease in Patients With RET Fusion-Positive NSCLC Treated With Selpercatinib.
Murciano-Goroff YR; Falcon CJ; Lin ST; Chacko C; Grimaldi G; Liu D; Wilhelm C; Iasonos A; Drilon A
J Thorac Oncol; 2023 May; 18(5):620-627. PubMed ID: 36657661
[TBL] [Abstract] [Full Text] [Related]
10. Normofractionated irradiation and not temozolomide modulates the immunogenic and oncogenic phenotype of human glioblastoma cell lines.
Schatz J; Ladinig A; Fietkau R; Putz F; Gaipl US; Frey B; Derer A
Strahlenther Onkol; 2023 Dec; 199(12):1140-1151. PubMed ID: 36480032
[TBL] [Abstract] [Full Text] [Related]
11. Spectroscopic characterization and in vitro studies of biological activity of bradykinin derivatives.
Proniewicz E; Burnat G; Domin H; Iłowska E; Roman A; Prahl A
Sci Rep; 2022 Nov; 12(1):19015. PubMed ID: 36348016
[TBL] [Abstract] [Full Text] [Related]
12. Analysis of patients without and with an initial triple-negative breast cancer diagnosis in the phase 3 randomized ASCENT study of sacituzumab govitecan in metastatic triple-negative breast cancer.
O'Shaughnessy J; Brufsky A; Rugo HS; Tolaney SM; Punie K; Sardesai S; Hamilton E; Loirat D; Traina T; Leon-Ferre R; Hurvitz SA; Kalinsky K; Bardia A; Henry S; Mayer I; Zhu Y; Phan S; Cortés J
Breast Cancer Res Treat; 2022 Sep; 195(2):127-139. PubMed ID: 35545724
[TBL] [Abstract] [Full Text] [Related]
13. Cerebrospinal Fluid Extracellular Vesicles with Distinct Properties in Autoimmune Encephalitis and Herpes Simplex Encephalitis.
Li Y; Gu J; Mao Y; Wang X; Li Z; Xu X; Chen H; Gui Y
Mol Neurobiol; 2022 Apr; 59(4):2441-2455. PubMed ID: 35083659
[TBL] [Abstract] [Full Text] [Related]
14. Hsa_circ_0076931 suppresses malignant biological properties, down-regulates miR-6760-3p through direct binding, and up-regulates CCBE1 in glioma.
Ke Y; Su S; Duan C; Wang Y; Cao G; Fang Z; Tuo Y; Li W; Wang Z; Zhang S
Biosci Rep; 2022 Jan; 42(1):. PubMed ID: 34931668
[TBL] [Abstract] [Full Text] [Related]
15. Overexpression of Hepatocyte growth factor and its soluble receptor (s-cMet) in the serum of patients with different grades of meningioma.
Mashayekhi F; Sasani ST; Saberi A; Salehi Z
J Clin Neurosci; 2021 Nov; 93():1-5. PubMed ID: 34656230
[TBL] [Abstract] [Full Text] [Related]
16. Successful osimertinib rechallenge following subsequent chemotherapy regimen in a patient with metastatic non-small cell lung carcinoma: a case report.
Han ZJ; Luo N; Li L; Liu ZL
Ann Palliat Med; 2021 Jul; 10(7):8413-8419. PubMed ID: 33977727
[TBL] [Abstract] [Full Text] [Related]
17. Hsp70 chaperone blocks α-synuclein oligomer formation via a novel engagement mechanism.
Tao J; Berthet A; Citron YR; Tsiolaki PL; Stanley R; Gestwicki JE; Agard DA; McConlogue L
J Biol Chem; 2021; 296():100613. PubMed ID: 33798554
[TBL] [Abstract] [Full Text] [Related]
18. Nm23-H1 inhibits the proliferation of glioma cells via regulation of PKC signaling pathway.
Pan F; Ji F; Xu Z; Nie W; Zhou W
J BUON; 2021; 26(1):152-158. PubMed ID: 33721446
[TBL] [Abstract] [Full Text] [Related]
19. Primate-specific histone variants.
Ding D; Nguyen TT; Pang MYH; Ishibashi T
Genome; 2021 Apr; 64(4):337-346. PubMed ID: 33245240
[TBL] [Abstract] [Full Text] [Related]
20. MicroRNA‑422a functions as a tumor suppressor in glioma by regulating the Wnt/β‑catenin signaling pathway via RPN2.
Sun J; Chen Z; Xiong J; Wang Q; Tang F; Zhang X; Mo L; Wang C; Fan W; Wang J
Oncol Rep; 2020 Nov; 44(5):2108-2120. PubMed ID: 33000268
[TBL] [Abstract] [Full Text] [Related]
[Next]
